BMY 20844
BMY 20844 is an orally active platelet cAMP phosphodiesterase inhibitor with anti-thrombosis activity. BMY 20844 can elevate cAMP levels and activate protein kinase in platelets. BMY 20844 can be used for the research of cardiovascular disease[1][2].
Product Specifications
CAS Number
124886-01-7
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O=C1N=C2NC3=CC=C(C)C(C)=C3C=C2N1
Molecular Formula
C12H11N3O
Molecular Weight
213.24
References & Citations
[1]Seiler S, et al. Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets. Thromb Res. 1991 Apr;62 (1-2) :31-42.|[2]Buchanan JO, et al. Pharmacology of a potent, new antithrombotic agent, 1,3-dihydro-7,8-dimethyl-2H-imidazo[4,5-b]quinolin-2-one (BMY-20844) . Thromb Res. 1989 Nov 1;56 (3) :333-46.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC041098-500 1x 500 µL
Cyclin B1 (CCNB1/1098), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471706-100 1x 100 µL
S100B (Astrocyte and Melanoma Marker) (S100B/1706R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC682395-500 1x 500 µL
CD25/ IL2RA (Activated Lymphocyte Marker) (IL2RA/2395), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940952-500 1x 500 µL
Human IgG Immunoglobulin (B33/20), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040485-500 1x 500 µL
ODC-1 (Ornithine Decarboxylase-1) (ODC1/485), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401074-500 1x 500 µL
SOX10 (SOX10/991 + SOX10/1074), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details